Loading...
Vitura Health Limited
VIT.AX•ASX
HealthcareDrug Manufacturers - Specialty & Generic
A$0.07
A$0.001(1.47%)
Vitura Health Limited (VIT.AX) Financial Performance & Statements
Review Vitura Health Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
5.56%
↑ 5.56%
Operating Income Growth
-75.50%
↓ 75.50%
Net Income Growth
-74.57%
↓ 74.57%
Operating Cash Flow Growth
-27.92%
↓ 27.92%
Operating Margin
2.41%
↑ 2.41%
Gross Margin
26.44%
↑ 26.44%
Net Profit Margin
1.54%
↑ 1.54%
ROE
4.88%
↑ 4.88%
ROIC
5.70%
↑ 5.70%
Vitura Health Limited (VIT.AX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Vitura Health Limited stock.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
Revenue | $63.90M | $59.97M | $59.70M | $29.85M |
Cost of Revenue | $47.29M | $51.82M | $47.86M | $19.97M |
Gross Profit | $16.60M | $8.16M | $11.84M | $9.88M |
Gross Profit Ratio | $0.26 | $0.14 | $0.20 | $0.33 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $16.35M | $3.54M | $3.23M | $5.57M |
Operating Expenses | $16.35M | $3.54M | $3.23M | $5.64M |
Total Costs & Expenses | $63.65M | $55.36M | $51.09M | $25.61M |
Interest Income | $656136.00 | $341804.00 | $268443.00 | $174602.00 |
Interest Expense | $1.14M | $299827.00 | $110774.00 | $0.00 |
Depreciation & Amortization | $227170.00 | $660659.00 | $443133.00 | $84760.00 |
EBITDA | $475488.00 | $5.62M | $9.38M | $4.39M |
EBITDA Ratio | $0.007 | $0.09 | $0.15 | $0.15 |
Operating Income | $248320.00 | $4.62M | $8.61M | $4.31M |
Operating Income Ratio | $0.004 | $0.08 | $0.14 | $0.14 |
Other Income/Expenses (Net) | -$438620.00 | $40609.00 | $218377.00 | $109189.00 |
Income Before Tax | -$190300.00 | $4.66M | $8.83M | $4.41M |
Income Before Tax Ratio | -$0.003 | $0.08 | $0.15 | $0.15 |
Income Tax Expense | -$446608.00 | $1.54M | $2.74M | $1.37M |
Net Income | $242712.00 | $3.27M | $6.13M | $3.06M |
Net Income Ratio | $0.004 | $0.05 | $0.10 | $0.10 |
EPS | $0.00 | $0.006 | $0.01 | $0.005 |
Diluted EPS | $0.00 | $0.006 | $0.01 | $0.005 |
Weighted Avg Shares Outstanding | $591.98M | $564.05M | $556.53M | $567.67M |
Weighted Avg Shares Outstanding (Diluted) | $589.55M | $568.52M | $571.55M | $571.60M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan